Acorda Therapeutics Inc Unternehmenswert
Was ist das Unternehmenswert von Acorda Therapeutics Inc?
Unternehmenswert von Acorda Therapeutics Inc ist $569.58M
Was ist die Definition von Unternehmenswert?
Der Unternehmenswert ist ein Maß für den gesamten Marktwert eines Unternehmens. Es wird als Marktkapitalisierung mit Verschuldung, Minderheitsanteilen und Vorzugsaktien abzüglich der Zahlungsmittel und Zahlungsmitteläquivalente berechnet.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Unternehmenswert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit unternehmenswert ähnlich Acorda Therapeutics Inc
- Heidelberger Druckmaschinen AG hat Unternehmenswert von $567.55M
- IQE Plc hat Unternehmenswert von $568.18M
- Artemis Gold hat Unternehmenswert von $568.28M
- Royal Nickel hat Unternehmenswert von $568.77M
- DCB Bank hat Unternehmenswert von $568.97M
- Social Capital Hedosophia IV hat Unternehmenswert von $569.42M
- Acorda Therapeutics Inc hat Unternehmenswert von $569.58M
- DCB Bank hat Unternehmenswert von $569.78M
- HeidelbergCement India hat Unternehmenswert von $569.90M
- Wajax hat Unternehmenswert von $570.24M
- Hollywood Bowl Plc hat Unternehmenswert von $571.02M
- Digital Media Solutions hat Unternehmenswert von $571.18M
- Jamna Auto Industries hat Unternehmenswert von $571.40M